276 related articles for article (PubMed ID: 30838685)
1. Associations of statin use with glycaemic traits and incident type 2 diabetes.
Ahmadizar F; Ochoa-Rosales C; Glisic M; Franco OH; Muka T; Stricker BH
Br J Clin Pharmacol; 2019 May; 85(5):993-1002. PubMed ID: 30838685
[TBL] [Abstract][Full Text] [Related]
2. Diabetogenic Action of Statins: Mechanisms.
Carmena R; Betteridge DJ
Curr Atheroscler Rep; 2019 Apr; 21(6):23. PubMed ID: 31037345
[TBL] [Abstract][Full Text] [Related]
3. Statin Use, Diabetes Incidence and Overall Mortality in Normoglycemic and Impaired Fasting Glucose Patients.
Castro MR; Simon G; Cha SS; Yawn BP; Melton LJ; Caraballo PJ
J Gen Intern Med; 2016 May; 31(5):502-8. PubMed ID: 26850412
[TBL] [Abstract][Full Text] [Related]
4. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
5. Relationship of hyperinsulinaemia, insulin resistance and β-cell dysfunction with incident diabetes and pre-diabetes: the Tehran Lipid and Glucose Study.
Derakhshan A; Tohidi M; Arshi B; Khalili D; Azizi F; Hadaegh F
Diabet Med; 2015 Jan; 32(1):24-32. PubMed ID: 25131451
[TBL] [Abstract][Full Text] [Related]
6. Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease.
van de Woestijne AP; van der Graaf Y; Westerink J; Nathoe HM; Visseren FL
Am J Cardiol; 2015 Feb; 115(4):441-6. PubMed ID: 25554536
[TBL] [Abstract][Full Text] [Related]
7. Atherogenic dyslipidemia increases the risk of incident diabetes in statin-treated patients with impaired fasting glucose or obesity.
Barkas F; Elisaf M; Liberopoulos E; Liamis G; Ntzani EE; Rizos EC
J Cardiol; 2019 Sep; 74(3):290-295. PubMed ID: 30910387
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Link Between Statin Therapy and Type 2 Diabetes.
Ochoa-Rosales C; Portilla-Fernandez E; Nano J; Wilson R; Lehne B; Mishra PP; Gao X; Ghanbari M; Rueda-Ochoa OL; Juvinao-Quintero D; Loh M; Zhang W; Kooner JS; Grabe HJ; Felix SB; Schöttker B; Zhang Y; Gieger C; Müller-Nurasyid M; Heier M; Peters A; Lehtimäki T; Teumer A; Brenner H; Waldenberger M; Ikram MA; van Meurs JBJ; Franco OH; Voortman T; Chambers J; Stricker BH; Muka T
Diabetes Care; 2020 Apr; 43(4):875-884. PubMed ID: 32033992
[TBL] [Abstract][Full Text] [Related]
9. Diabetes Secondary to Treatment with Statins.
Laakso M; Kuusisto J
Curr Diab Rep; 2017 Feb; 17(2):10. PubMed ID: 28155189
[TBL] [Abstract][Full Text] [Related]
10. Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study.
Hulman A; Simmons RK; Brunner EJ; Witte DR; Færch K; Vistisen D; Ikehara S; Kivimaki M; Tabák AG
Diabetologia; 2017 Jul; 60(7):1252-1260. PubMed ID: 28409212
[TBL] [Abstract][Full Text] [Related]
11. Statins and their increased risk of inducing diabetes.
Agouridis AP; Kostapanos MS; Elisaf MS
Expert Opin Drug Saf; 2015; 14(12):1835-44. PubMed ID: 26437128
[TBL] [Abstract][Full Text] [Related]
12. Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study.
Anyanwagu U; Mamza J; Donnelly R; Idris I
Cardiovasc Diabetol; 2017 Aug; 16(1):107. PubMed ID: 28830436
[TBL] [Abstract][Full Text] [Related]
13. Plasma triglyceride determination can identify increased risk of statin-induced type 2 diabetes: a hypothesis.
Armato J; Ruby R; Reaven G
Atherosclerosis; 2015 Apr; 239(2):401-4. PubMed ID: 25682039
[TBL] [Abstract][Full Text] [Related]
14. Genetic risk scores in the prediction of plasma glucose, impaired insulin secretion, insulin resistance and incident type 2 diabetes in the METSIM study.
Stančáková A; Kuulasmaa T; Kuusisto J; Mohlke KL; Collins FS; Boehnke M; Laakso M
Diabetologia; 2017 Sep; 60(9):1722-1730. PubMed ID: 28573393
[TBL] [Abstract][Full Text] [Related]
15. Effect of statins on fasting glucose in non-diabetic individuals: nationwide population-based health examination in Korea.
Kim J; Lee HS; Lee KY
Cardiovasc Diabetol; 2018 Dec; 17(1):155. PubMed ID: 30518364
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort.
Cederberg H; Stančáková A; Yaluri N; Modi S; Kuusisto J; Laakso M
Diabetologia; 2015 May; 58(5):1109-17. PubMed ID: 25754552
[TBL] [Abstract][Full Text] [Related]
17. Fasting plasma triglyceride concentration: A possible approach to identify increased risk of statin-induced type 2 diabetes.
Sung KC; Reaven G
Diab Vasc Dis Res; 2015 Sep; 12(5):373-6. PubMed ID: 25966738
[TBL] [Abstract][Full Text] [Related]
18. Impact of insulin sensitivity, beta-cell function and glycaemic control on initiation of second-line glucose-lowering treatment in newly diagnosed type 2 diabetes.
Rathmann W; Strassburger K; Bongaerts B; Bobrov P; Kuss O; Müssig K; Markgraf DF; Szendroedi J; Herder C; Roden M;
Diabetes Obes Metab; 2017 Jun; 19(6):866-873. PubMed ID: 28127851
[TBL] [Abstract][Full Text] [Related]
19. Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk.
Izzo R; de Simone G; Trimarco V; Giudice R; De Marco M; Di Renzo G; De Luca N; Trimarco B
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1101-6. PubMed ID: 23419735
[TBL] [Abstract][Full Text] [Related]
20. Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study.
Na E; Cho S; Kim DJ; Choi J; Han E
Cardiovasc Diabetol; 2020 May; 19(1):67. PubMed ID: 32416728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
